This consultation closed on 17 November 2020
Consultation period20 October 2020 to 17 November 2020
The APVMA invites comment on the proposed use of cyproconazole and azoxystrobin in the product Amistar Xtra Fungicide, for use on pulses.
We invite written comment from 21 October 2020 to 17 November 2020 on the trade implications of this proposal.
The APVMA is able to consider comments relating to the legislative grounds for the assessment, which are the trade implications of the use of the product. The Trade Advice Notice provides a summary of the APVMA's residue and trade assessment.
Please note: Submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential (see public submission coversheet).
Please lodge your submission with a public submission coversheet, which provides options for how your submission will be published.
Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.
Please send your written submission and coversheet by email or post to:
Executive Director, Risk Assessment Capability
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001
The APVMA sought comments from interested stakeholders on the proposed use of cyproconazole and azoxystrobin in the product Amistar Xtra Fungicide for use on pulses, in a consultation that closed on 17 November 2020.
A total of 2 submissions were received from industry bodies.
A copy of the published submission is available on our website.
We have completed our review of all submissions and the Residues and Trade assessment for this application has been finalised.